Use of MIB-1 (Ki-67) immunoreactivity in differentiating grade II and grade III gliomas

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 8, 1997, Pages 857-865

  Hsu, Dora W ^a,b   Louis, David N ^a,b   Efird, Jimmy T ^a   Hedley Whyte, E Tessa ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Astrocytoma; Glioma; Immunocytochemistry; Ki 67; MIB 1; Proliferative index

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CENTRAL NERVOUS SYSTEM TUMOR; FEMALE; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR DIAGNOSIS;

EID: 0030756094     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199708000-00003     Document Type: Article

References (33)

1. Coons SW, Johnson PC. Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index. J Neuropathol Exp Neurol 1993;52:609-18
2. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. World Health Organization, Sobin LH, ed. Second ed. Berlin-Heidelberg-New York: Springer-Verlag, 1993:11-14
3. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988;62:2152-65
4. Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: Application to surgical neuropathology. Am J Surg Pathol 1986;10:611-17
5. Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (Berl) 1987;74:179-82
6. Zuber P, Hamou MF, de Tribolet N. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery 1988;22:364-68
7. Shibuya M, Ito S, Miwa T, Davis RL, Wilson CB, Hoshino T Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Cancer 1993;71:199-206
8. Montine TJ, Vandersteenhoven JJ, Aguzzi A, et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 1994;34:674-79
9. Wakimoto H, Aoyagi M, Nakayama T, et al. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 1996;77:373-80
10. Kiss R, Dewitte O, Decaestecker C, et al. The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors. Am J Clin Pathol 1997;107:321-31
11. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-15
12. Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63
13. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-73
14. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer 1994;74:1921-26
15. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T. Ki-67 immunoreactivity in human central nervous system tumors: A study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 1994;87:47-54
16. Sallinen PK, Haapasalo HK, Visakorpi T, et al. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 1994;174:275-82
17. Hsu DW, Efird JT, Hedley-Whyte ET. Prognostic role of urokinasetype plasminogen activator in human gliomas. Am J Pathol 1995;147:114-23
18. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-802
19. Wright P. Adjusting p-values for simultaneous inference. Biometrics 1992;48:1005-13
20. Kim TS, Halliday AL, Hedley-Whyte ET, Convery K. Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg 1991;74:27-37
21. Jaros E, Perry RH, Adam L, et al. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 1992;66:373-85
22. Ellison DW, Steart PV, Bateman AC, Pickering RM, Palmer JD, Weller RO. Prognostic indicators in a range of astrocytic tumours: An immunohistochemical study with Ki-67 and p53 antibodies. J Neurol Neurosurg Psych 1995;59:413-19
23. Bruno S, Dazynkiewicz Z. Cell cycle dependent expression and stability of the nuclear antigen detected by Ki-67 antibody in HL-60 cells. Cell Prolif 1992;25:31-40
24. Raghavan R, Steart PV, Weller RO. Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas and glioblastoma multiforme: A Ki-67 study. Neuropathol Appl Neurobiol 1990;16:123-33
25. Louis DN, Edgerton S, Thor AD, Hedley-Whyte ET. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: A comparative study. Acta Neuropathol 1991;81:675-79
26. Coons SW, Johnson PC, Pearl DK. Prognostic significance of flow cytometry deoxyribonucleic acid analysis of human astrocytomas. Neurosurgery 1994;35:119-26
27. Pigott TJD, Lowe JS, Palmer J. Statistical modeling in analysis of prognosis in glioblastoma multiforme: A study of clinical variables and Ki-67 index. Br J Neurosurg 1991;5:61-66
28. Coons SW, Johnson PC. KJ-67/MIB-1 labeling index predicts patient survival in low grade and anaplastic astrocytomas [abstract]. J Neuropathol Exp Neurol 1996;55:656
29. Swanson PE. HIERanarchy: The state of the art in immunohistochemistry. Am J Clin Pathol 1997;107:139-40
30. Patsouris E, Stocker U, Kallmeyer V, Keiditsch E, Mehraein P, Stavrou S. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors. Anti-cancer Res 1988;8:537-44
31. Kamel OW, LeBrun DP, Davis RE, Berry GJ, Warnke RA. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/cyclin 19A2: Correlation with Ki-67 labeling. Am J Pathol 1991;138:1471-77
32. Morimura T, Kitz K, Budka H. In situ analysis of cell kinetics in human brain tumors: A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67. Acta Neuropathol 1989;77:276-82
33. Decken M, Reifenberger G, Wechsler W. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 1989;115:179-88